These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

594 related items for PubMed ID: 9045904

  • 1. CD56bright natural killer cell subsets: characterization of distinct functional responses to interleukin-2 and the c-kit ligand.
    Carson WE, Fehniger TA, Caligiuri MA.
    Eur J Immunol; 1997 Feb; 27(2):354-60. PubMed ID: 9045904
    [Abstract] [Full Text] [Related]

  • 2. Differential responses to interleukin 2 define functionally distinct subsets of human natural killer cells.
    Baume DM, Robertson MJ, Levine H, Manley TJ, Schow PW, Ritz J.
    Eur J Immunol; 1992 Jan; 22(1):1-6. PubMed ID: 1370410
    [Abstract] [Full Text] [Related]

  • 3. The effect of interleukin 2 and transforming growth factor-beta 2 (TGF-beta 2) on the proliferation and natural killer activity of decidual CD16- CD56bright natural killer cells.
    Saito S, Morii T, Enomoto M, Sakakura S, Nishikawa K, Narita N, Ichijo M.
    Cell Immunol; 1993 Dec; 152(2):605-13. PubMed ID: 7504983
    [Abstract] [Full Text] [Related]

  • 4. Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells.
    Gaddy J, Broxmeyer HE.
    Cell Immunol; 1997 Sep 15; 180(2):132-42. PubMed ID: 9341743
    [Abstract] [Full Text] [Related]

  • 5. Comparative studies of human FcRIII-positive and negative natural killer cells.
    Nagler A, Lanier LL, Cwirla S, Phillips JH.
    J Immunol; 1989 Nov 15; 143(10):3183-91. PubMed ID: 2530273
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Induction of CD16+ CD56bright NK cells with antitumour cytotoxicity not only from CD16- CD56bright NK Cells but also from CD16- CD56dim NK cells.
    Takahashi E, Kuranaga N, Satoh K, Habu Y, Shinomiya N, Asano T, Seki S, Hayakawa M.
    Scand J Immunol; 2007 Feb 15; 65(2):126-38. PubMed ID: 17257217
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Phenotypic analysis of a resting subpopulation of human peripheral blood NK cells: the FcR gamma III (CD16) molecule and NK cell differentiation.
    Warren HS, Skipsey LJ.
    Immunology; 1991 Jan 15; 72(1):150-7. PubMed ID: 1825480
    [Abstract] [Full Text] [Related]

  • 12. Interleukin-8 production by CD16-CD56bright natural killer cells in the human early pregnancy decidua.
    Saito S, Kasahara T, Sakakura S, Enomoto M, Umekage H, Harada N, Morii T, Nishikawa K, Narita N, Ichijo M.
    Biochem Biophys Res Commun; 1994 Apr 15; 200(1):378-83. PubMed ID: 7513162
    [Abstract] [Full Text] [Related]

  • 13. IL-7 enhances survival of human CD56bright NK cells.
    Michaud A, Dardari R, Charrier E, Cordeiro P, Herblot S, Duval M.
    J Immunother; 2010 May 15; 33(4):382-90. PubMed ID: 20386468
    [Abstract] [Full Text] [Related]

  • 14. Differential expression and function of L-selectin on CD56bright and CD56dim natural killer cell subsets.
    Frey M, Packianathan NB, Fehniger TA, Ross ME, Wang WC, Stewart CC, Caligiuri MA, Evans SS.
    J Immunol; 1998 Jul 01; 161(1):400-8. PubMed ID: 9647249
    [Abstract] [Full Text] [Related]

  • 15. Phenotypically and functionally distinct subsets of natural killer cells in human PBMCs.
    Fan YY, Yang BY, Wu CY.
    Cell Biol Int; 2008 Feb 01; 32(2):188-97. PubMed ID: 17920947
    [Abstract] [Full Text] [Related]

  • 16. G-CSF-mobilized CD34+ cells cultured in interleukin-2 and stem cell factor generate a phenotypically novel monocyte.
    Sconocchia G, Fujiwara H, Rezvani K, Keyvanfar K, El Ouriaghli F, Grube M, Melenhorst J, Hensel N, Barrett AJ.
    J Leukoc Biol; 2004 Dec 01; 76(6):1214-9. PubMed ID: 15345723
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.